IMV Inc. (IMV) Stock
IMV is no longer traded. IMV was delisted from the Nasdaq in June 2023.
Prices on this page are historical; the last trade was June 26, 2023 at $0.08.
IMV stock price history
IMV final trading statistics
- Final close
- $0.08
- Final trading day
- Jun 26, 2023
- Market cap at delisting
- $9.81M
- Shares outstanding
- 11.71M
- Final 52-week range
- $0.00 – $4.43
- Avg. volume (final 3 mo.)
- 96,195
- All-time high (split-adj.)
- $1747.05 · Dec 2017
- All-time low (split-adj.)
- $0.05 · May 2023
- Return since IPO
- -99.1%
- Beta
- 1.52
- Book value / share
- -$0.69
- Price / book
- -0.12
IMV annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2022 | $0.00 | -$38.5M | -$4.59 |
| FY2021 | $0.00 | -$37.5M | -$4.80 |
| FY2020 | $2.4K | -$27.4M | -$5.90 |
| FY2019 | $45.2K | -$21.9M | -$5.60 |
| FY2018 | $60.2K | -$17.1M | -$0.50 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About IMV Inc.
IMV Inc. operates as a clinical-stage immuno-oncology company. The company develops a portfolio of therapies based on DPX its immune-educating technology platform for treatment of solid and hematological cancers. The company's lead drug candidate includes maveropepimut-S, a DPX-based immunotherapy that targets survivin-expressing cells that is Phase II clinical trials for diffuse large B cell lymphoma; ovarian cancer; and bladder, liver, and MSI-H solid tumors, as well as in Phase I clinical trial for breast cancer. It also develops DPX-SurMAGE that is in Phase I clinical trial for bladder cancer; and DPX-COVID-19 and DPX-RSV for infectious diseases. The company was formerly known as Immunovaccine Inc. and changed its name to IMV Inc. in May 2018. IMV Inc. was founded in 2000 and is headquartered in Dartmouth, Canada.
IMV stock FAQ
What happened to IMV stock?
IMV stock was delisted from the Nasdaq. Its final close was $0.08 on June 26, 2023.
Is IMV stock still trading?
No. IMV was delisted from the Nasdaq in June 2023 and no longer trades on a U.S. exchange.
What was the last price of IMV stock?
IMV closed at $0.08 on its final trading day, June 26, 2023, for a market value of about $9.81M.
What were IMV's revenue and earnings in its last full fiscal year?
IMV reported revenue of $0.00 and net income of -$38.5M in fiscal 2022, its last full year as a public company.
When did IMV go public?
IMV Inc. stock began trading on June 1, 2018.